|
|
Previous Article | Table of Contents | Next Article 
Differential rates of somatic hypermutation in V(H) genes among subsets of
chronic lymphocytic leukemia defined by chromosomal abnormalities
DG Oscier, A Thompsett, D Zhu and FK Stevenson
Department of Haematology, Royal Bournemouth Hospital, UK.
Chronic lymphocytic leukemia (CLL) is a B-cell tumor involving small
lymphocytes that generally express the CD5 antigen and low levels of
surface Ig. Within this definition, there is heterogeneity among cases in
cell morphology, karyotypic abnormalities, and clinical course. Trisomy 12,
the most frequent karyotypic abnormality, is commonly found in a subset of
CLL with atypical morphology. It has also been associated with advanced
disease, and possibly with a less favorable prognosis. A further subset of
cases with abnormalities involving chromosome 13q14 have typical lymphocyte
morphology. Occasionally, the two abnormalities are found together. To
assess the clonal history of the cell of origin in disease subsets defined
by these two chromosomal abnormalities, we investigated the usage of V(H)
genes and the pattern of somatic mutation in 10 cases of trisomy 12 with
atypical morphology and eight cases of 13q14 abnormality with typical
morphology. In addition, four cases with both chromosomal abnormalities
were analyzed. Results confirm a common usage of the V(H)1 family in all
subsets. However, the patterns of somatic mutation were distinct, with
cases of trisomy 12 showing a minimal level of mutation (mean +/- SD, 0.34%
+/- 0.86%) and cases of 13q14 abnormality showing significant levels (6.5%
+/- 1.67%). The four cases with both abnormalities showed a mixed pattern.
All mutated cases had intraclonal homogeneity, and three of 10 had a
pattern indicative of antigen selection. These results suggest that the
clonal history of the two subsets of CLL may differ.
Volume 89,
Issue 11,
pp. 4153-4160,
06/01/1997
Copyright © 1997 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. BOELENS, S. LUST, B. VANHOECKE, and F. OFFNER
Chronic Lymphocytic Leukaemia
Anticancer Res,
February 1, 2009;
29(2):
605 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sargent, D. Jones, L. V. Abruzzo, H. Yao, J. Bonderover, M. Cisneros, W. G. Wierda, M. J. Keating, and R. Luthra
Customized Oligonucleotide Array-Based Comparative Genomic Hybridization as a Clinical Assay for Genomic Profiling of Chronic Lymphocytic Leukemia
J. Mol. Diagn.,
January 1, 2009;
11(1):
25 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O V Moshynska and A Saxena
Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma
J. Clin. Pathol.,
April 1, 2008;
61(4):
438 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Muntanola, F. Bosch, P. Arguis, E. Arellano-Rodrigo, C. Ayuso, E. Gine, M. Crespo, P. Abrisqueta, C. Moreno, F. Cobo, et al.
Abdominal Computed Tomography Predicts Progression in Patients With Rai Stage 0 Chronic Lymphocytic Leukemia
J. Clin. Oncol.,
April 20, 2007;
25(12):
1576 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dicker, S. Schnittger, T. Haferlach, W. Kern, and C. Schoch
Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression
Blood,
November 1, 2006;
108(9):
3152 - 3160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Chng, R. F. Schop, T. Price-Troska, I. Ghobrial, N. Kay, D. F. Jelinek, M. A. Gertz, A. Dispenzieri, M. Lacy, R. A. Kyle, et al.
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma
Blood,
October 15, 2006;
108(8):
2755 - 2763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Hus, M. Podhorecka, A. Bojarska-Junak, J. Rolinski, M. Schmitt, M. Sieklucka, E. Wasik-Szczepanek, and A. Dmoszynska
The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia
Ann. Onc.,
April 1, 2006;
17(4):
683 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mayr, M. R. Speicher, D. M. Kofler, R. Buhmann, J. Strehl, R. Busch, M. Hallek, and C.-M. Wendtner
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia
Blood,
January 15, 2006;
107(2):
742 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Chiorazzi, K. R. Rai, and M. Ferrarini
Chronic Lymphocytic Leukemia
N. Engl. J. Med.,
February 24, 2005;
352(8):
804 - 815.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Widhopf II, L. Z. Rassenti, T. L. Toy, J. G. Gribben, W. G. Wierda, and T. J. Kipps
Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins
Blood,
October 15, 2004;
104(8):
2499 - 2504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Shanafelt and T. G. Call
Current Approach to Diagnosis and Management of Chronic Lymphocytic Leukemia
Mayo Clin. Proc.,
March 1, 2004;
79(3):
388 - 398.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wiestner, A. Rosenwald, T. S. Barry, G. Wright, R. E. Davis, S. E. Henrickson, H. Zhao, R. E. Ibbotson, J. A. Orchard, Z. Davis, et al.
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile
Blood,
June 15, 2003;
101(12):
4944 - 4951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Crespo, F. Bosch, N. Villamor, B. Bellosillo, D. Colomer, M. Rozman, S. Marce, A. Lopez-Guillermo, E. Campo, and E. Montserrat
ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia
N. Engl. J. Med.,
May 1, 2003;
348(18):
1764 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Keating, N. Chiorazzi, B. Messmer, R. N. Damle, S. L. Allen, K. R. Rai, M. Ferrarini, and T. J. Kipps
Biology and Treatment of Chronic Lymphocytic Leukemia
Hematology,
January 1, 2003;
2003(1):
153 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cerutti, H. Zan, E. C. Kim, S. Shah, E. J. Schattner, A. Schaffer, and P. Casali
Ongoing In Vivo Immunoglobulin Class Switch DNA Recombination in Chronic Lymphocytic Leukemia B Cells
J. Immunol.,
December 1, 2002;
169(11):
6594 - 6603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ruzickova, A. Pruss, M. Odendahl, K. Wolbart, G.-R. Burmester, J. Scholze, T. Dorner, and A. Hansen
Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in VH4-34 expressing single leukemic B cells
Blood,
October 16, 2002;
100(9):
3419 - 3422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gurrieri, P. McGuire, H. Zan, X.-J. Yan, A. Cerutti, E. Albesiano, S. L. Allen, V. Vinciguerra, K. R. Rai, M. Ferrarini, et al.
Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin VHDJH Gene Diversification
J. Exp. Med.,
September 2, 2002;
196(5):
629 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Oscier, A. C. Gardiner, S. J. Mould, S. Glide, Z. A. Davis, R. E. Ibbotson, M. M. Corcoran, R. M. Chapman, P. W. Thomas, J. A. Copplestone, et al.
Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors
Blood,
July 30, 2002;
100(4):
1177 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Damle, F. Ghiotto, A. Valetto, E. Albesiano, F. Fais, X.-J. Yan, C. P. Sison, S. L. Allen, J. Kolitz, P. Schulman, et al.
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes
Blood,
May 13, 2002;
99(11):
4087 - 4093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhu, H. McCarthy, C. H. Ottensmeier, P. Johnson, T. J. Hamblin, and F. K. Stevenson
Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma
Blood,
April 1, 2002;
99(7):
2562 - 2568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Taylor, J. A. Pittman, K. Seeberger, M. J. Mant, T. Reiman, A. R. Belch, and L. M. Pilarski
Intraclonal Homogeneity of Clonotypic Immunoglobulin M and Diversity of Nonclinical Post-Switch Isotypes in Multiple Myeloma: Insights into the Evolution of the Myeloma Clone
Clin. Cancer Res.,
February 1, 2002;
8(2):
502 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Klein, Y. Tu, G. A. Stolovitzky, M. Mattioli, G. Cattoretti, H. Husson, A. Freedman, G. Inghirami, L. Cro, L. Baldini, et al.
Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells
J. Exp. Med.,
December 3, 2001;
194(11):
1625 - 1638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hara, N. Nakamura, T. Kuze, Y. Hashimoto, Y. Sasaki, A. Shirakawa, M. Furuta, K. Yago, K. Kato, and M. Abe
Immunoglobulin Heavy Chain Gene Analysis of Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma
Invest. Ophthalmol. Vis. Sci.,
October 1, 2001;
42(11):
2450 - 2457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Matrai, K. Lin, M. Dennis, P. Sherrington, M. Zuzel, A. R Pettitt, and J. C. Cawley
CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia
Blood,
March 15, 2001;
97(6):
1902 - 1902.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pasqualucci, A. Neri, L. Baldini, R. Dalla-Favera, and A. Migliazza
BCL-6 Mutations Are Associated with Immunoglobulin Variable Heavy Chain Mutations in B-Cell Chronic Lymphocytic Leukemia
Cancer Res.,
October 1, 2000;
60(20):
5644 - 5648.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. W. Bahler, N. S. Aguilera, C. C. Chen, S. L. Abbondanzo, and S. H. Swerdlow
Histological and Immunoglobulin VH Gene Analysis of Interfollicular Small Lymphocytic Lymphoma Provides Evidence for Two Types
Am. J. Pathol.,
October 1, 2000;
157(4):
1063 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M A Hoeve, A D G Krol, K Philippo, P W B Derksen, R A Veenendaal, E Schuuring, P. M Kluin, and J H J M v. Krieken
Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction
Mol. Pathol.,
August 1, 2000;
53(4):
194 - 200.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. S. Sahota, Z. Davis, T. J. Hamblin, and F. K. Stevenson
Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia
Blood,
June 1, 2000;
95(11):
3534 - 3540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sakai, G. E. Marti, N. Caporaso, S. Pittaluga, J. W. Touchman, F. Fend, and M. Raffeld
Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL
Blood,
February 15, 2000;
95(4):
1413 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Damle, T. Wasil, F. Fais, F. Ghiotto, A. Valetto, S. L. Allen, A. Buchbinder, D. Budman, K. Dittmar, J. Kolitz, et al.
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
Blood,
September 15, 1999;
94(6):
1840 - 1847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Hamblin, Z. Davis, A. Gardiner, D. G. Oscier, and F. K. Stevenson
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Blood,
September 15, 1999;
94(6):
1848 - 1854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Sahota, R. Garand, R. Mahroof, A. Smith, N. Juge-Morineau, F. K. Stevenson, and R. Bataille
VH Gene Analysis of IgM-Secreting Myeloma Indicates an Origin From a Memory Cell Undergoing Isotype Switch Events
Blood,
August 1, 1999;
94(3):
1070 - 1076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Caligaris-Cappio and T. J. Hamblin
B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather
J. Clin. Oncol.,
January 1, 1999;
17(1):
399 - 399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K.A. Mongini, Q. Liu, M. A. Vilensky, P. F. Highet, and J. K. Inman
Evidence for an Upper Affinity Threshold for Anti-IgM-Induced Apoptosis in a Human B-Cell Lymphoma
Blood,
November 15, 1998;
92(10):
3756 - 3771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.M. Aarts, R. Willemze, R.J. Bende, C.J.L.M. Meijer, S.T. Pals, and C.J.M. van Noesel
VH Gene Analysis of Primary Cutaneous B-Cell Lymphomas: Evidence for Ongoing Somatic Hypermutation and Isotype Switching
Blood,
November 15, 1998;
92(10):
3857 - 3864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Ottensmeier, A. R. Thompsett, D. Zhu, B. S. Wilkins, J. W. Sweetenham, and F. K. Stevenson
Analysis of VH Genes in Follicular and Diffuse Lymphoma Shows Ongoing Somatic Mutation and Multiple Isotype Transcripts in Early Disease With Changes During Disease Progression
Blood,
June 1, 1998;
91(11):
4292 - 4299.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|